Delivery Order SPE2DB22D2108-SPE2DB25FU5YP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10 tablets, with a ceiling value of $59,932.80 and an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Oseltamivir, an antiviral medication...
- The Defense Logistics Agency awarded a delivery order valued at $6,974.99 to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 26, 2025, and was awarded on September 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a $1,547.04 firm fixed price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10s. The contract, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a competitively awarded, non-set-aside delivery order. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a $4,553.92 firm fixed price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. The contract was competitively awarded without a set-aside designation and carries an ultimate completion date of September 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $2,368.80 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Oseltamivir 6 mg/ml suspension in 60ml quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 17, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This federal contract award is a delivery order valued at $1,494.60 placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of 4,563,471,961 units of the drug Oseltamivir Phosphate 75 mg capsules, an antiviral medication used to treat and prevent influenza. The contract has an ultimate completion date of January 30, 2024 and was awarded on January 29, 2024. It is a firm fixed-price contract with no set-aside...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Oseltamivir Phosphate 75 mg capsules. The contract has a ceiling value of $6,534.13 and runs through March 19, 2025. It is a firm-fixed price contract with no set-aside designation, indicating open competition. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
- This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,109.24 firm fixed-price contract is for the delivery of Oseltamivir Phosphate 75 mg capsules, which are used to treat influenza. The award is under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir 6 mg/ml Suspension in 60ml quantities, valued at $1,055.36. This is a firm fixed price delivery order with no set-aside designation, executed on September 19, 2025, with an ultimate completion date of September 22, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- This federal contract award, valued at $1,272.14, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,646,936 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules, with an ultimate completion date of October 31, 2023. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU5YPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. This competitively awarded, firm fixed-price contract carries a ceiling value of $3,699.10 and is scheduled for completion by September 25, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $1 billion and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as a primary supplier of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's extensive federal contract portfolio demonstrates consistent capability in fulfilling competitive procurement requirements across diverse therapeutic domains. Oseltamivir, an antiviral medication commonly used for influenza treatment and prophylaxis, represents the type of critical medical commodity that AmerisourceBergen regularly supplies to support military and federal healthcare operations through its comprehensive pharmaceutical prime vendor agreements with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 9/24/25 |